Cargando…
A Randomized, Placebo‐Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome
BACKGROUND: New pharmacological targets are needed for restless legs syndrome. Preclinical data suggest that a hypoadenosinergic state plays an important pathogenetic role. OBJECTIVE: The objective of this study was to determine whether inhibitors of equilibrative nucleoside transporters, for exampl...
Autores principales: | Garcia‐Borreguero, Diego, Garcia‐Malo, Celia, Granizo, Juan José, Ferré, Sergi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530834/ https://www.ncbi.nlm.nih.gov/pubmed/34137476 http://dx.doi.org/10.1002/mds.28668 |
Ejemplares similares
-
Treating restless legs syndrome in the context of sleep disordered breathing comorbidity
por: Romero-Peralta, Sofía, et al.
Publicado: (2019) -
Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome
por: Ferré, Sergi, et al.
Publicado: (2018) -
Consensus guidelines on the construct validity of rodent models of restless legs syndrome
por: Salminen, Aaro V., et al.
Publicado: (2022) -
Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome
por: Rodrigues, Matilde S., et al.
Publicado: (2022) -
Restless legs syndrome: Over 50 years of European contribution
por: Khachatryan, Samson G., et al.
Publicado: (2022)